Interactive Investor
>>

Hikma Pharmaceuticals (LSE:HIK) Share Price

HIK

Hikma Pharmaceuticals

UK company

Right Arrow 1

Healthcare

Right Arrow 2

Drug Manufacturers - Specialty & Generic

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XLON

-

Updated: -

Research

News & analysis

Regulatory news

Loading...

Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

Company Profile

Founded in the Middle East with headquarters in London, Hikma manufactures generic and in-licensed pharmaceuticals. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

LSE:HIK

GB00B0LCW083

GBX

Loading...

Loading Comparison

Latest HIK News

HIK Regulatory News